Photo: Joe Raedle/Getty Images

Bernie Sanders' 2020 presidential campaign said Thursday that it raised $34.5 million in 2019's fourth quarter, the New York Times reports.

Why it matters: Sanders' haul is the most any candidate has raised in a single quarter so far in the Democratic primary race, easily surpassing the $25.3 million he raked in during Q3.

  • Sanders received more than 1.8 million donations in the quarter, with an average donation of $18.53.

The state of play: While Sanders is one of the first candidates to announce his fundraising for the quarter, it's unlikely to be topped by any of his competitors.

  • Pete Buttigieg's campaign said it raised $24.7 million during the same span, while Andrew Yang's campaign announced it had pulled in $16.5 million.
  • Elizabeth Warren's campaign warned its supporters last week that it had only raised $17 million, triggering a fundraising push to reach $20 million by the end of the year.

Go deeper: Bernie Sanders releases letters from doctors deeming him fit for presidency

Go deeper

Updated 47 mins ago - Politics & Policy

Coronavirus dashboard

Illustration: Aïda Amer/Axios

  1. Politics: Chris Christie: Wear a mask "or you may regret it — as I did" — Senate Democrats block vote on McConnell's targeted relief bill.
  2. Business: New state unemployment filings fall.
  3. Economy: Why the stimulus delay isn't a crisis (yet).
  4. Health: FDA approves Gilead's remdesivir as a coronavirus treatment How the pandemic might endMany U.S. deaths were avoidable.
  5. Education: Boston and Chicago send students back home for online learning.
  6. World: Spain and France exceed 1 million cases.

FBI: Russian hacking group stole data after targeting local governments

FBI Headquarters. Photo: Mark Wilson/Getty Images

Energetic Bear, a Russian state-sponsored hacking group, has stolen data from two servers after targeting state and federal government networks in the U.S. since at least September, the FBI and Cybersecurity and Infrastructure Security Agency said on Thursday.

Driving the news: Director of National Intelligence John Ratcliffe announced Wednesday that Iran and Russia had obtained voter registration information that could be used to undermine confidence in the U.S. election system.

FDA approves Gilead's remdesivir as a coronavirus treatment

A production line of Remdesivir. Photo: Fadel Dawood/picture alliance via Getty Images

Gilead Sciences on Thursday received approval from the Food and Drug Administration for remdesivir, an antiviral treatment that has shown modest results against treating COVID-19.

Why it matters: It's the first and only fully FDA-approved drug in the U.S. for treating the coronavirus.